CHE · Chemed Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $657.51M | - | $624.90M | $618.80M | $646.94M | - | $606.18M | $595.88M | $589.23M | - |
| Cost of Revenue | $441.75M | - | $427.99M | $434.11M | $430.53M | - | $396.19M | $389.75M | $385.13M | - |
| Gross Profit | $215.76M | - | $196.91M | $184.69M | $216.41M | - | $209.99M | $206.13M | $204.11M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $114.32M | - | $105.78M | $100.32M | $105.59M | - | $101.98M | $102.25M | $115.87M | - |
| Total Operating Expenses | $572.93M | - | $514.02M | $507.75M | $516.90M | - | $514.02M | $507.75M | $516.90M | - |
| D&A | $16.87M | - | $13.66M | $13.69M | $16.02M | - | $13.15M | $13.17M | $15.81M | - |
| Operating Income | $84.58M | - | $74.75M | $68.08M | $94.76M | - | $92.16M | $88.13M | $72.33M | - |
| Interest Expense | $512.0K | - | $457.0K | $443.0K | $329.0K | - | $427.0K | $429.0K | $425.0K | - |
| Income Tax | $22.54M | - | $19.31M | $18.62M | $23.92M | - | $25.25M | $22.94M | $19.47M | - |
| Net Income | $66.30M | - | $64.24M | $52.49M | $71.76M | - | $75.78M | $70.89M | $65.02M | - |
| EPS - Basic | $4.85 | - | $4.46 | $3.60 | $4.91 | - | $5.04 | $4.70 | $4.30 | - |
| EPS - Diluted | $4.84 | - | $4.46 | $3.57 | $4.86 | - | $5.00 | $4.65 | $4.24 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.86M | $74.52M | $129.75M | $249.90M | $173.88M | $178.35M | $238.45M | $222.90M | $313.35M | $263.96M |
| Accounts Receivable | $215.48M | $182.57M | $215.57M | $184.88M | $285.87M | $171.16M | $196.48M | $184.96M | $177.33M | $181.51M |
| Inventory | $7.21M | $7.54M | $8.24M | $9.15M | $7.79M | $8.19M | $9.90M | $10.73M | $10.71M | $12.00M |
| Accounts Payable | $65.70M | $64.46M | $48.09M | $50.86M | $47.69M | $44.15M | $44.94M | $43.00M | $56.20M | $64.03M |
| Current Assets | $274.06M | $302.62M | $395.24M | $491.38M | $502.38M | $394.75M | $490.44M | $464.61M | $539.62M | $500.84M |
| Total Assets | $1.54B | $1.54B | $1.62B | $1.72B | $1.73B | $1.67B | $1.77B | $1.73B | $1.73B | $1.67B |
| Current Liabilities | $321.42M | $287.13M | $292.04M | $263.89M | $290.56M | $285.69M | $264.78M | $261.75M | $281.97M | $312.05M |
| Long-term Debt | $91.20M | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $687.82M | $558.78M | $546.94M | $519.36M | $544.75M | $549.58M | $533.68M | $527.69M | $544.14M | $560.22M |
| Stockholders' Equity | $847.99M | $979.40M | $1.08B | $1.20B | $1.18B | $1.12B | $1.24B | $1.21B | $1.18B | $1.11B |
| Retained Earnings | $3.01B | $2.96B | $2.89B | $2.83B | $2.79B | $2.72B | $2.64B | $2.57B | $2.51B | $2.45B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $88.22M | - | - | - | $32.74M | - | - | - | $84.55M | - |
| Investing Cash Flow | ($37.79M) | - | - | - | ($13.67M) | - | - | - | ($19.39M) | - |
| Financing Cash Flow | ($108.09M) | - | - | - | ($23.54M) | - | - | - | ($15.77M) | - |
| CapEx | $17.12M | - | $18.65M | $15.81M | $13.28M | - | - | - | $12.16M | - |
| Free Cash Flow | $71.10M | - | - | - | $19.46M | - | - | - | $72.39M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 32.8% | - | 31.5% | 29.8% | 33.5% | - | 34.6% | 34.6% | 34.6% | - |
| Operating margin | 12.9% | - | 12.0% | 11.0% | 14.6% | - | 15.2% | 14.8% | 12.3% | - |
| EBITDA margin | 15.4% | - | 14.1% | 13.2% | 17.1% | - | 17.4% | 17.0% | 15.0% | - |
| Net margin | 10.1% | - | 10.3% | 8.5% | 11.1% | - | 12.5% | 11.9% | 11.0% | - |
| Free cash flow margin | 10.8% | - | - | - | 3.0% | - | - | - | 12.3% | - |
| FCF / Net income | 1.07 | - | - | - | 0.27 | - | - | - | 1.11 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 17.4% | - | 16.9% | 16.2% | 16.3% | - | 16.8% | 17.2% | 19.7% | - |
| Effective tax rate | 25.4% | - | 23.1% | 26.2% | 25.0% | - | 25.0% | 24.5% | 23.0% | - |
| Return on assets | 4.3% | - | 4.0% | 3.1% | 4.2% | - | 4.3% | 4.1% | 3.8% | - |
| Return on equity | 7.8% | - | 6.0% | 4.4% | 6.1% | - | 6.1% | 5.9% | 5.5% | - |
| Return on invested capital | 6.7% | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.85 | 1.05 | 1.35 | 1.86 | 1.73 | 1.38 | 1.85 | 1.78 | 1.91 | 1.61 |
| Quick ratio | 0.83 | 1.03 | 1.33 | 1.83 | 1.70 | 1.35 | 1.81 | 1.73 | 1.88 | 1.57 |
| Cash ratio | 0.05 | 0.26 | 0.44 | 0.95 | 0.60 | 0.62 | 0.90 | 0.85 | 1.11 | 0.85 |
| Leverage | ||||||||||
| Debt / Equity | 0.11 | - | - | - | - | - | - | - | - | - |
| Debt / Assets | 0.06 | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | 0.90 | - | - | - | - | - | - | - | - | - |
| Interest coverage | 165.2x | - | 163.6x | 153.7x | 288.0x | - | 215.8x | 205.4x | 170.2x | - |
| Equity multiplier | 1.81 | 1.57 | 1.51 | 1.43 | 1.46 | 1.49 | 1.43 | 1.44 | 1.46 | 1.51 |
| Liabilities / Assets | 0.45 | 0.36 | 0.34 | 0.30 | 0.32 | 0.33 | 0.30 | 0.30 | 0.31 | 0.34 |
| Efficiency | ||||||||||
| Asset turnover | 0.43 | - | 0.38 | 0.36 | 0.37 | - | 0.34 | 0.34 | 0.34 | - |
| Inventory turnover | 61.29 | - | 51.95 | 47.45 | 55.27 | - | 40.02 | 36.31 | 35.95 | - |
| Days sales outstanding | 120d | - | 126d | 109d | 161d | - | 118d | 113d | 110d | - |
| Days inventory outstanding | 6d | - | 7d | 8d | 7d | - | 9d | 10d | 10d | - |
| Days payable outstanding | 54d | - | 41d | 43d | 40d | - | 41d | 40d | 53d | - |
| Cash conversion cycle | 71d | - | 92d | 74d | 127d | - | 86d | 83d | 67d | - |
| Valuation | ||||||||||
| P / E | 78.0x | - | 100.4x | 136.4x | 126.6x | - | 120.2x | 116.7x | 151.4x | - |
| P / B | 6.1x | - | 6.0x | 6.0x | 7.7x | - | 7.4x | 6.9x | 8.3x | - |
| P / S | 7.9x | - | 10.3x | 11.6x | 14.0x | - | 15.0x | 13.9x | 16.7x | - |
| EV / EBITDA | 51.7x | - | 71.5x | 84.5x | 80.4x | - | 84.3x | 79.5x | 108.2x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 1.6% | - | 3.1% | 3.8% | 9.8% | - | 7.4% | 7.6% | 5.2% | - |
| Revenue CAGR (3y) | 5.5% | - | 5.9% | 5.2% | 6.8% | - | 4.0% | 3.8% | 3.8% | - |
| Revenue CAGR (5y) | 4.5% | - | 3.4% | 4.3% | 4.6% | - | 4.8% | 6.2% | 6.1% | - |
| Gross profit growth (YoY) | -0.3% | - | -6.2% | -10.4% | 6.0% | - | 3.9% | 14.8% | 7.7% | - |
| Operating income growth (YoY) | -10.7% | - | -18.9% | -22.7% | 31.0% | - | 6.1% | 26.8% | -0.7% | - |
| Net income growth (YoY) | -7.6% | - | -15.2% | -25.9% | 10.4% | - | 1.1% | 32.8% | 20.1% | - |
| EPS growth (YoY) | -0.4% | - | -10.8% | -23.2% | 14.6% | - | 1.4% | 32.5% | 18.4% | - |
| EPS CAGR (3y) | 10.6% | - | 5.7% | -6.7% | 4.8% | - | 3.2% | 9.8% | 1.9% | - |
| EPS CAGR (5y) | 3.8% | - | 1.5% | -6.6% | 7.5% | - | 7.0% | 8.6% | 9.4% | - |
| FCF growth (YoY) | 265.3% | - | - | - | -73.1% | - | - | - | 66.5% | - |
| FCF CAGR (5y) | -4.4% | - | - | - | -22.5% | - | - | - | 3.9% | - |
| Book value growth (YoY) | -28.2% | -12.5% | -12.9% | -0.7% | -0.1% | 1.0% | 21.2% | 26.8% | 34.5% | 38.7% |
Peer comparison
Same SIC group: Services-Home Health Care Services
Comparing CHEMED CORP against the 5 most active filers in the same SIC group.
Dividends
$2.40/share trailing 12 months · +20.0% YoY
| Ex-date | Per share |
|---|---|
| May 28, 2026 | $0.6000 |
| Feb 23, 2026 | $0.6000 |
| Nov 17, 2025 | $0.6000 |
| Aug 11, 2025 | $0.6000 |
| May 29, 2025 | $0.5000 |
| Feb 24, 2025 | $0.5000 |
| Nov 18, 2024 | $0.5000 |
| Aug 12, 2024 | $0.5000 |
| May 30, 2024 | $0.4000 |
| Feb 23, 2024 | $0.4000 |
| Nov 10, 2023 | $0.4000 |
| Aug 11, 2023 | $0.4000 |
| May 24, 2023 | $0.3800 |
| Feb 24, 2023 | $0.3800 |
| Nov 10, 2022 | $0.3800 |
| Aug 12, 2022 | $0.3800 |
| May 25, 2022 | $0.3600 |
| Feb 25, 2022 | $0.3600 |
| Nov 12, 2021 | $0.3600 |
| Aug 13, 2021 | $0.3600 |
| May 26, 2021 | $0.3400 |
| Feb 26, 2021 | $0.3400 |
| Nov 13, 2020 | $0.3400 |
| Aug 14, 2020 | $0.3400 |